SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Olive polyphenols as modulators of amyloid aggregation: mechanisms and implications for neurodegenerative diseases.

Food Funct · 2025-11-10

DOI: 10.1039/d5fo03331dPMID: 41111331

Check source for accessReview; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

The Mediterranean diet is well known for its role in promoting healthy aging and reducing the risk of chronic diseases, with extra virgin olive oil (EVOO) recognized as a key contributor to these benefits. Among EVOO's constituents, minor phenolic compounds have emerged as principal mediators of its biological activity. Given the pivotal role of amyloid aggregation in protein misfolding disorders (PMDs), considerable research over the past two decades has focused on amyloidogenic proteins and the discovery of natural compounds capable of modulating their aggregation. This review summarizes current evidence on the anti-amyloidogenic properties of olive-derived polyphenols, emphasizing their mechanisms of action and therapeutic relevance in two major neurodegenerative diseases, Alzheimer's and Parkinson's. Additionally, insights from molecular modeling studies are discussed to elucidate the structural basis of interactions between these polyphenols and amyloid proteins, shedding light on their influence on aggregation pathways.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.